What Is the NeoAg Summit?
Returning to Boston for the 5th year, the Neoantigen Based Therapies Summit is the only industry-focused meeting dedicated solely to the full end-to-end development and commercialization of neoantigen-based cancer immunotherapies.
Join this exclusive community of over 300+ leading industry experts, and navigate three tracks of content, as we discuss how to maximise immunogenicity, and streamline manufacturing processes to improve the clinical and commercial development of neoantigen based immunotherapies.
Expert Speakers Include
Hear What Our Attendees Say
"Great opportunity to learn how to develop and accelerate neoantigen related products not only from speakers but also participants and partners."
"The Neoantigen Summit is the focal point for updates in the cancer neoantigen vaccine field and should be attended by everybody with a keen interest in the field."